HTG Molecular Diagnostics (HTGM) Tops Q3 EPS by 9c

HTG Molecular Diagnostics (NASDAQ: HTGM) reported Q3 EPS of ($0.76), $0.09 better than the analyst estimate of ($0.85). Revenue for the quarter came in at $1 million versus the consensus estimate of $1.07 million.

For earnings history and earnings-related data on HTG Molecular Diagnostics (HTGM) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• SuperCom (SPCB) Tops Q3 EPS by 43c
• Jefferies upgrades Five Below to Buy, sees path to TJX-like re-rating